Frost Phillip MD Et Al's Form 4 filing
Cocrystal Pharma, Inc. (COCP) · filed Nov 28, 2025
- Accession no.
- 0001493152-25-025314
- Filed
- Nov 28, 2025
- Trade date
- Nov 26, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $3.98K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Frost Phillip MD Et AlCIK 0000898860 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 26, 2025 | Common Stock | PPurchaseAcquired | +1,500 | $1.00 | +$1,500 | 1,701,051 | Indirect | |
| Nov 26, 2025 | Common Stock | PPurchaseAcquired | +2,500 | $0.99 | +$2,475 | 1,703,551 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.